iLoF receives EUR 1.5m capital injection to research treatment for Alzheimer's disease
|
04 AUG 2024
|
Intel ID : 397564
|
||||
| Intel ID | 397564 | ||
| Value | EUR 1,50m | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - iLoF
(31 Dec 2023) |
Revenue: EUR 1,71m EBITDA: EUR 0,01m People: 20 |
||
| Date |
 |
||
| Country |  |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
30.04.04 Outcome Management (Primary) 30 Healthcare / 30.04 Healthcare Information & Technology Systems |
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.04.04 Outcome Management 30 Healthcare / 30.04 Healthcare Information & Technology Systems |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.